Feasibility Study of Resection and GammaTile Followed by Concomitant External Beam Radiation Therapy EBRT and Temozolomide TMZ and Adjuvant TMZ in Newly Diagnosed Glioblastoma GBM.

Brief Summary

Type:
Brain Tumors / Neurologic Cancers

Study Type:
Treatment

Phase:
Feasibility/Pilot

ClinicalTrials.gov Identifier:
NCT05342883

Study #:
STUDY00148936

Start Date:
Apr 30, 2023

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05342883

View Complete Trial Details & Eligibility at ClinicalTrials.gov